Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Antiviral Res. 2019 Apr 13;167:83–88. doi: 10.1016/j.antiviral.2019.04.007

Table 2.

In-vitro pharmacokinetic parameters of bictegravir (BIC) as NP and solution.

PK Parameter/106 cells Unit BIC NP BIC Solution
Cmax pmole 888.54 ± 226.73 372.3 ± 137.54
AUCall h × pmole 31,654.77 ± 4186.15 10,053.24 ± 1187.96
Clearance pmole/(h × pmole) 0.010 0.044

Data represents mean ± standard error of means (SE), n = 3; AUCall = area under the plasma concentration-time curve (from 0-end of experiment).